ABSTRACT
BACKGROUND: Higher bone mass in blacks than in whites has been related to greater calcium utilization efficiency. Dietary calcium requirements for maximal skeletal calcium accretion during puberty may differ between the races. OBJECTIVE: This study compared the relation between calcium intake and calcium retention in black and white adolescent girls. DESIGN: A range of controlled calcium intakes (760-1981 mg Ca/d) were used in 3-wk controlled balance studies. Some subjects were studied more than once; a total of 182 observations from 55 black girls and 66 white girls were analyzed. RESULTS: Blacks had 185 +/- 32 mg/d greater mean skeletal calcium retention than did whites (P < 0.0001) at all calcium intakes as a result of significantly greater net calcium absorption (P < 0.001) and lower calcium excretion (P < 0.0001). CONCLUSIONS: Dietary calcium requirements did not differ with race. Higher calcium retention at all calcium intakes during adolescence may underlie the higher bone mineral content of adult blacks than of adult whites.
Subject(s)
Black People , Bone Density , Bone and Bones/metabolism , Calcium/metabolism , White People , Absorption , Adolescent , Biomarkers/blood , Bone and Bones/chemistry , Calcium/administration & dosage , Calcium/analysis , Calcium, Dietary/administration & dosage , Dietary Supplements , Female , HumansSubject(s)
Hyponatremia/etiology , N-Methyl-3,4-methylenedioxyamphetamine/adverse effects , Substance-Related Disorders/complications , Adolescent , Brain Diseases/etiology , Eating/drug effects , Female , Fluid Therapy/methods , Glasgow Coma Scale , Humans , Hyponatremia/drug therapy , Seizures/etiology , Unconsciousness/etiologySubject(s)
Bone and Bones/metabolism , Calcium/metabolism , Models, Biological , Adolescent , Adult , Aging/physiology , Bone Density , Bone Development , Child , Female , Humans , Intestinal Absorption , KineticsABSTRACT
Seven trained male cyclists (ate 22.3 +/- 2 years) participated in 4 separate supplementation phases. They ingested 2 capsules per day containing the following treatments: placebo (placebo plus placebo); vitamin C (1 g per day vitamin C plus placebo); vitamin C and E (1 g per day vitamin C plus 200 IU per kg vitamin E); and vitamin E (400 IU per kg vitamin E plus placebo). The treatment order (placebo, vitamin C, vitamin C and E, and vitamin E) was the same for all subjects. Performance trials consisting of a 60-minute steady state ride (SSR) and a 30-minute performance ride (PR) on Cybex 100 Metabolic cycles were performed after each trial. Workloads of 70% of the VO2max were set for the SSR and PR rides, with pedal rate maintained at 90 rpm (SSR) or self determined (PR). Blood samples (5 ml) were drawn pre- and postexercise and analyzed for malonaldehyde (MDA) and lactic acid. The results indicate that vitamin E treatment was more effective than vitamin C alone or vitamin C and E. Pre-exercise plasma levels of MDA in the vitamin E trial was 39% below the pre-exercise MDA levels of the placebo: 2.94 +/- 0.54 and 4.81 +/- 0.65 micromol per ml, respectively. Plasma MDA following exercise in the vitamin E group was also lower than teh placebo: 4.32 +/- 0.37 vs 7.89 +/- 1.0 micromol per ml, respectively. Vitamin C supplementation, on the other hand, elevated both the resting and exercise plasma levels of MDA. None of th supplemental phases had any significant effect on performance. In conclusion, the results indicate that 400 IU/day of vitamin E reduces membrane damage more effectively than vitamin C but does not enhance performance. Athletes are encouraged to include antioxidants, such as vitamin E and C, in their diet to counteract these detrimental effects of exercise. The data presented here suggests that 400 IU/day of vitamin E will provide adequate protection but supplementing the diet with 1 g per day of vitamin C may promote cellular damage. However neither of these vitamins, either alone or in combination, will enhance exercise performance.